Table of Content

1 Industrial Chain Overview

• 1.1 Pulmonary Drugs Industry
  • 1.1.1 Overview
  • 1.1.2 Characteristics of Pulmonary Drugs
• 1.2 Upstream
  • 1.2.1 Major Materials
  • 1.2.2 Manufacturing Overview
• 1.3 Product List By Type
  • 1.3.1 Inhaled Corticosteroids (ICS)
  • 1.3.2 Long-Acting Beta2-Agonists (LABA)
  • 1.3.3 Antihistamine
  • 1.3.4 Vasodilators
  • 1.3.5 Short-Acting Beta2-Agonists (SABA)
  • 1.3.6 Anticholinergics
  • 1.3.7 Combination Drugs
  • 1.3.8 MAbs
  • 1.3.9 Enzymes
  • 1.3.10 Antibiotics & Antileukotrienes
• 1.4 End-Use List
  • 1.4.1 Demand in Asthma & COPD
  • 1.4.2 Demand in Allergic Rhinitis
  • 1.4.3 Demand in Pulmonary Arterial Hypertension
  • 1.4.4 Demand in Cystic Fibrosis
• 1.5 Global Market Overview
  • 1.5.1 Global Market Size and Forecast, 2015-2025
  • 1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
  • 1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
  • 1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025

2 Global Production & Consumption by Geography

• 2.1 Global Production & Consumption
  • 2.1.1 Global Production
  • 2.1.2 Global Consumption
• 2.2 Geographic Production & Consumption
  • 2.2.1 Production
    • 2.2.1.1 Asia-Pacific
    • 2.2.1.2 North America
    • 2.2.1.3 South America
    • 2.2.1.4 Europe
    • 2.2.1.5 Middle East & Africa
  • 2.2.2 Consumption
    • 2.2.2.1 Asia-Pacific
    • 2.2.2.2 North America
    • 2.2.2.3 South America
    • 2.2.2.4 Europe
    • 2.2.2.5 Middle East & Africa

  3 Major Manufacturers Introduction

  • 3.1 Manufacturers Overview
  • 3.2 Manufacturers List
    • 3.2.1 AstraZeneca plc Overview
      • 3.2.1.1 Product Specifications
      • 3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.1.3 Recent Developments
      • 3.2.1.4 Future Strategic Planning
    • 3.2.2 Bayer AG Overview
      • 3.2.2.1 Product Specifications
      • 3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.2.3 Recent Developments
      • 3.2.2.4 Future Strategic Planning
    • 3.2.3 Teva Pharmaceutical Industries Ltd Overview
      • 3.2.3.1 Product Specifications
      • 3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.3.3 Recent Developments
      • 3.2.3.4 Future Strategic Planning
    • 3.2.4 Actelion Pharmaceuticals, Inc. Overview
      • 3.2.4.1 Product Specifications
      • 3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.4.3 Recent Developments
      • 3.2.4.4 Future Strategic Planning
    • 3.2.5 Boehringer Ingelheim GmbH Overview
      • 3.2.5.1 Product Specifications
      • 3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.5.3 Recent Developments
      • 3.2.5.4 Future Strategic Planning
    • 3.2.6 F. Hoffmann-La Roche Ltd. Overview
      • 3.2.6.1 Product Specifications
      • 3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.6.3 Recent Developments
      • 3.2.6.4 Future Strategic Planning
    • 3.2.7 Merck & Co., Inc. Overview
      • 3.2.7.1 Product Specifications
      • 3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.7.3 Recent Developments
      • 3.2.7.4 Future Strategic Planning
    • 3.2.8 Novartis AG Overview
      • 3.2.8.1 Product Specifications
      • 3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.8.3 Recent Developments
      • 3.2.8.4 Future Strategic Planning
    • 3.2.9 GlaxoSmithKline plc Overview
      • 3.2.9.1 Product Specifications
      • 3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.9.3 Recent Developments
      • 3.2.9.4 Future Strategic Planning
    • 3.2.10 Sunovion Pharmaceuticals Overview
      • 3.2.10.1 Product Specifications
      • 3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.10.3 Recent Developments
      • 3.2.10.4 Future Strategic Planning

    4 Market Competition Pattern

    • 4.1 Market Size and Sketch
    • 4.2 Company Market Share
      • 4.2.1 Global Production by Major Manufacturers
      • 4.2.2 Market Concentration Analysis
    • 4.3 Market News and Trend
      • 4.3.1 Merger & Acquisition
      • 4.3.2 New Product Launch

    5 Product Type Segment

    • 5.1 Global Overview by Product Type Segment
    • 5.2 Segment Subdivision by Product Type
      • 5.2.1 Market in Inhaled Corticosteroids (ICS)
        • 5.2.1.1 Market Size
        • 5.2.1.2 Situation & Development
      • 5.2.2 Market in Long-Acting Beta2-Agonists (LABA)
        • 5.2.2.1 Market Size
        • 5.2.2.2 Situation & Development
      • 5.2.3 Market in Antihistamine
        • 5.2.3.1 Market Size
        • 5.2.3.2 Situation & Development
      • 5.2.4 Market in Vasodilators
        • 5.2.4.1 Market Size
        • 5.2.4.2 Situation & Development
      • 5.2.5 Market in Short-Acting Beta2-Agonists (SABA)
        • 5.2.5.1 Market Size
        • 5.2.5.2 Situation & Development
      • 5.2.6 Market in Anticholinergics
        • 5.2.6.1 Market Size
        • 5.2.6.2 Situation & Development
      • 5.2.7 Market in Combination Drugs
        • 5.2.7.1 Market Size
        • 5.2.7.2 Situation & Development
      • 5.2.8 Market in MAbs
        • 5.2.8.1 Market Size
        • 5.2.8.2 Situation & Development
      • 5.2.9 Market in Enzymes
        • 5.2.9.1 Market Size
        • 5.2.9.2 Situation & Development
      • 5.2.10 Market in Antibiotics & Antileukotrienes
        • 5.2.10.1 Market Size
        • 5.2.10.2 Situation & Development

      6 End-Use Segment

      • 6.1 Global Overview by End-Use Segment
      • 6.2 Segment Subdivision
        • 6.2.1 Market in Asthma & COPD
          • 6.2.1.1 Market Size
          • 6.2.1.2 Situation & Development
        • 6.2.2 Market in Allergic Rhinitis
          • 6.2.2.1 Market Size
          • 6.2.2.2 Situation & Development
        • 6.2.3 Market in Pulmonary Arterial Hypertension
          • 6.2.3.1 Market Size
          • 6.2.3.2 Situation & Development
        • 6.2.4 Market in Cystic Fibrosis
          • 6.2.4.1 Market Size
          • 6.2.4.2 Situation & Development

        7 Market Forecast & Trend

        • 7.1 Regional Forecast
        • 7.2 Consumption Forecast
          • 7.2.1 Product Type Forecast
          • 7.2.2 End-Use Forecast
        • 7.3 Investment Trend
        • 7.4 Consumption Trend

        8 Price & Channel

        • 8.1 Price and Cost
          • 8.1.1 Price
          • 8.1.2 Cost
        • 8.2 Channel Segment

        9 Market Drivers & Investment Environment

        • 9.1 Market Drivers
        • 9.2 Investment Environment

        10 Research Conclusion

        List of Tables

        Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025

        Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025

        Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025

        Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume

        Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD

        Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume

        Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD

        Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Major Manufacturers Headquarters and Contact Information

        Table Major Manufacturers Capacity List in 2018

        Table AstraZeneca plc Overview List

        Table Pulmonary Drugs Business Operation of AstraZeneca plc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Bayer AG Overview List

        Table Pulmonary Drugs Business Operation of Bayer AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Teva Pharmaceutical Industries Ltd Overview List

        Table Pulmonary Drugs Business Operation of Teva Pharmaceutical Industries Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Actelion Pharmaceuticals, Inc. Overview List

        Table Pulmonary Drugs Business Operation of Actelion Pharmaceuticals, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Boehringer Ingelheim GmbH Overview List

        Table Pulmonary Drugs Business Operation of Boehringer Ingelheim GmbH (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table F. Hoffmann-La Roche Ltd. Overview List

        Table Pulmonary Drugs Business Operation of F. Hoffmann-La Roche Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Merck & Co., Inc. Overview List

        Table Pulmonary Drugs Business Operation of Merck & Co., Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Novartis AG Overview List

        Table Pulmonary Drugs Business Operation of Novartis AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table GlaxoSmithKline plc Overview List

        Table Pulmonary Drugs Business Operation of GlaxoSmithKline plc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Sunovion Pharmaceuticals Overview List

        Table Pulmonary Drugs Business Operation of Sunovion Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Global Production Volume List by Manufacturers, 2015-2018, in Volume

        Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume

        Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD

        Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume

        Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume

        Table Global Market Forecast by Region Segment 2019-2025, in Million USD

        Table Global Market Forecast by Region Segment 2019-2025, in Volume

        Table Global Market Amount by Product Type Segment 2019-2025, in Million USD

        Table Global Market Volume by Product Type Segment 2019-2025, in Volume

        Table Global Market Amount by End-Use Segment 2019-2025, in Million USD

        Table Global Market Volume by End-Use Segment 2019-2025, in Volume

        List of Figures

        Figure Pulmonary Drugs Picture List

        Figure Global Market Size and Forecast with Growth Rate, 2015-2025

        Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Global Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure North America Market Volume and Growth Rate, 2015-2018, in Volume

        Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

        Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Global Production Volume Share by Manufacturers in 2019, in Volume

        Figure Global Production Amount Share by Manufacturers in 2019, in Million USD

        Figure Global Market Amount and Growth Rate in Inhaled Corticosteroids (ICS), 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Inhaled Corticosteroids (ICS), 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Long-Acting Beta2-Agonists (LABA), 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Long-Acting Beta2-Agonists (LABA), 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Antihistamine, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Antihistamine, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Vasodilators, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Vasodilators, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Short-Acting Beta2-Agonists (SABA), 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Short-Acting Beta2-Agonists (SABA), 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Anticholinergics, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Anticholinergics, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Combination Drugs, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Combination Drugs, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in MAbs, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in MAbs, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Enzymes, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Enzymes, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Antibiotics & Antileukotrienes, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Antibiotics & Antileukotrienes, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Asthma & COPD, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Asthma & COPD, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Allergic Rhinitis, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Allergic Rhinitis, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Pulmonary Arterial Hypertension, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Pulmonary Arterial Hypertension, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Cystic Fibrosis, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Cystic Fibrosis, 2015-2018, in Volume

According to 99Strategy, the Global Pulmonary Drugs Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Pulmonary Drugs market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
AstraZeneca plc
Bayer AG
Teva Pharmaceutical Industries Ltd
Actelion Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Novartis AG
GlaxoSmithKline plc
Sunovion Pharmaceuticals
Key Product Type
Inhaled Corticosteroids (ICS)
Long-Acting Beta2-Agonists (LABA)
Antihistamine
Vasodilators
Short-Acting Beta2-Agonists (SABA)
Anticholinergics
Combination Drugs
MAbs
Enzymes
Antibiotics & Antileukotrienes
Market by Application
Asthma & COPD
Allergic Rhinitis
Pulmonary Arterial Hypertension
Cystic Fibrosis
Main Aspects covered in the Report
Overview of the Pulmonary Drugs market including production, consumption, status & forecast and market growth
2015-2018 historical data and 2019-2025 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development